Search

Your search keyword '"Nicely, Nathan I."' showing total 34 results

Search Constraints

Start Over You searched for: Author "Nicely, Nathan I." Remove constraint Author: "Nicely, Nathan I." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
34 results on '"Nicely, Nathan I."'

Search Results

3. Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

7. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain

10. Potent and broad HIV-neutralizing antibodies in memory B cells and plasma

15. Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies

16. Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved

17. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies

18. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

19. Fab-dimerized glycan-reactive antibodies neutralize HIV and are prevalent in humans and rhesus macaques

20. Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants

21. Cooperation between somatic mutation and germline-encoded residues enables antibody recognition of HIV-1 envelope glycans

22. Maternal Broadly Neutralizing Antibodies Select for Neutralization-Resistant Infant Transmitted/Founder HIV Variants

24. Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations

26. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk

28. Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates

29. Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice

30. Initiation of immune tolerance–controlled HIV gp41 neutralizing B cell lineages

31. Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee

32. Polyreactivity and Autoreactivity among HIV-1 Antibodies

33. Initiation of immune tolerance–controlled HIV gp41 neutralizing B cell lineages.

34. Lifetime of ground conformational state determines the activity of structured RNA.

Catalog

Books, media, physical & digital resources